

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * type I interferon signaling pathway (GO:0060337) | 7.34176263 |
| 2 | * cellular response to type I interferon (GO:0071357) | 7.34176263 |
| 3 | * response to type I interferon (GO:0034340) | 7.29684594 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 7.17456485 |
| 5 | regulation of interferon-alpha production (GO:0032647) | 6.74342748 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.52618307 |
| 7 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 6.03701787 |
| 8 | cellular response to virus (GO:0098586) | 5.59644228 |
| 9 | * response to interferon-alpha (GO:0035455) | 5.46499981 |
| 10 | negative regulation of viral genome replication (GO:0045071) | 5.13988910 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 5.11401518 |
| 12 | cellular response to interferon-beta (GO:0035458) | 5.08862532 |
| 13 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.08510220 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.94949570 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.94922131 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.94922131 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.93852069 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.93852069 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.93852069 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.93852069 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.93852069 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.93852069 |
| 23 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.88391840 |
| 24 | cellular response to exogenous dsRNA (GO:0071360) | 4.87595590 |
| 25 | response to interferon-beta (GO:0035456) | 4.79149675 |
| 26 | positive regulation of interferon-beta production (GO:0032728) | 4.71110424 |
| 27 | regulation of RIG-I signaling pathway (GO:0039535) | 4.68705890 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.64207875 |
| 29 | * cellular response to interferon-alpha (GO:0035457) | 4.61332618 |
| 30 | response to peptidoglycan (GO:0032494) | 4.54892744 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22681980 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.14448651 |
| 33 | negative regulation of cell killing (GO:0031342) | 4.14062436 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.14062436 |
| 35 | T cell migration (GO:0072678) | 4.10685944 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.07507786 |
| 37 | cellular response to interferon-gamma (GO:0071346) | 4.03701513 |
| 38 | B cell mediated immunity (GO:0019724) | 4.01305915 |
| 39 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.91291580 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.91204838 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.89730752 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88312299 |
| 43 | response to host immune response (GO:0052572) | 3.88312299 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.79031962 |
| 45 | cellular response to zinc ion (GO:0071294) | 3.77136157 |
| 46 | regulation of type 2 immune response (GO:0002828) | 3.75589190 |
| 47 | lymphocyte chemotaxis (GO:0048247) | 3.74122061 |
| 48 | * defense response to virus (GO:0051607) | 3.70942795 |
| 49 | regulation of response to interferon-gamma (GO:0060330) | 3.65625200 |
| 50 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.64376779 |
| 51 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.64314864 |
| 52 | response to interferon-gamma (GO:0034341) | 3.58948483 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.57251602 |
| 54 | detection of other organism (GO:0098543) | 3.56867993 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48982729 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.48452448 |
| 57 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.48452448 |
| 58 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.47898329 |
| 59 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.45215246 |
| 60 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.44230387 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.43466640 |
| 62 | response to host (GO:0075136) | 3.43466640 |
| 63 | response to host defenses (GO:0052200) | 3.43466640 |
| 64 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.41761527 |
| 65 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.41496158 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.41432954 |
| 67 | response to exogenous dsRNA (GO:0043330) | 3.38806045 |
| 68 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 3.38792914 |
| 69 | regulation of interferon-beta production (GO:0032648) | 3.35965232 |
| 70 | response to protozoan (GO:0001562) | 3.35184667 |
| 71 | detection of bacterium (GO:0016045) | 3.32649825 |
| 72 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.32265597 |
| 73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.32226012 |
| 74 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.31354970 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 3.30291533 |
| 76 | detection of external biotic stimulus (GO:0098581) | 3.30264892 |
| 77 | regulation of chronic inflammatory response (GO:0002676) | 3.28188188 |
| 78 | T-helper 1 type immune response (GO:0042088) | 3.27572479 |
| 79 | regulation of chemokine biosynthetic process (GO:0045073) | 3.25451491 |
| 80 | negative regulation of type 2 immune response (GO:0002829) | 3.23310508 |
| 81 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22989077 |
| 82 | respiratory burst (GO:0045730) | 3.22545922 |
| 83 | eosinophil chemotaxis (GO:0048245) | 3.22225439 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 3.22221194 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22135884 |
| 86 | positive regulation of response to cytokine stimulus (GO:0060760) | 3.20454797 |
| 87 | germinal center formation (GO:0002467) | 3.16960626 |
| 88 | natural killer cell activation involved in immune response (GO:0002323) | 3.15816174 |
| 89 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.15224486 |
| 90 | defense response to protozoan (GO:0042832) | 3.15010077 |
| 91 | regulation of defense response to virus by host (GO:0050691) | 3.14530938 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13791672 |
| 93 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.13556771 |
| 94 | positive regulation of interleukin-12 production (GO:0032735) | 3.12489392 |
| 95 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.12473773 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08467376 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 3.07890195 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07396150 |
| 99 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.07371139 |
| 100 | microglial cell activation (GO:0001774) | 3.06922817 |
| 101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.04957386 |
| 102 | regulation of interleukin-12 production (GO:0032655) | 3.04542093 |
| 103 | interferon-gamma secretion (GO:0072643) | 3.03817606 |
| 104 | negative regulation of viral process (GO:0048525) | 3.03814997 |
| 105 | regulation of viral genome replication (GO:0045069) | 3.03404733 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00705571 |
| 107 | negative regulation of type I interferon production (GO:0032480) | 2.97480619 |
| 108 | regulation of antigen processing and presentation (GO:0002577) | 2.96392511 |
| 109 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93964271 |
| 110 | monocyte chemotaxis (GO:0002548) | 2.93829235 |
| 111 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91202729 |
| 112 | macrophage activation (GO:0042116) | 2.91030095 |
| 113 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.90780190 |
| 114 | cell proliferation involved in metanephros development (GO:0072203) | 2.90690526 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.90491875 |
| 116 | lymphocyte mediated immunity (GO:0002449) | 2.90309608 |
| 117 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.90056839 |
| 118 | response to muramyl dipeptide (GO:0032495) | 2.89059091 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 2.88969974 |
| 120 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.88799297 |
| 121 | cytokine biosynthetic process (GO:0042089) | 2.88760114 |
| 122 | granulocyte activation (GO:0036230) | 2.88168024 |
| 123 | positive regulation of response to biotic stimulus (GO:0002833) | 2.86287983 |
| 124 | positive regulation of lymphocyte migration (GO:2000403) | 2.85799586 |
| 125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85064729 |
| 126 | positive regulation of T cell migration (GO:2000406) | 2.83685167 |
| 127 | regulation of mononuclear cell migration (GO:0071675) | 2.83022083 |
| 128 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82179549 |
| 129 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.81776707 |
| 130 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.81431688 |
| 131 | positive regulation of interleukin-17 production (GO:0032740) | 2.80614951 |
| 132 | regulation of natural killer cell differentiation (GO:0032823) | 2.80477003 |
| 133 | neutrophil activation (GO:0042119) | 2.80003733 |
| 134 | positive regulation of defense response to virus by host (GO:0002230) | 2.79763134 |
| 135 | eosinophil migration (GO:0072677) | 2.78637846 |
| 136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.78265306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.24749649 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.66014726 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.43709044 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 6.08334080 |
| 5 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.27753254 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.97431988 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62026865 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.27745105 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12590544 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10087061 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09820284 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08602390 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.97603578 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.93210640 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.46143239 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41557833 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38228079 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34631104 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00175984 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79151261 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73343527 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70321258 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62587074 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61393754 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 1.61267388 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57712977 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56619065 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55440211 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.53651549 |
| 30 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48939035 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44398156 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43695441 |
| 33 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42338444 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41366020 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36913515 |
| 36 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.34763078 |
| 37 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.32575609 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31848154 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29790643 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29279608 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.25676985 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23485866 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19473569 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17215547 |
| 45 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15998652 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15093358 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14244692 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14183850 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14075210 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12605838 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10484004 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08284150 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08269045 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08174656 |
| 55 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.07737862 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07695223 |
| 57 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06768217 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05282713 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04812490 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03915834 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02120239 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97332641 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95327844 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95187410 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95047697 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94613507 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92965386 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92382837 |
| 69 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.90788117 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89736471 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88074150 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88060627 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86920215 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85494512 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84387527 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 0.84369083 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83958179 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83778343 |
| 79 | * MAF_26560356_Chip-Seq_TH2_Human | 0.83756742 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82500112 |
| 81 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80783010 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80687583 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80312086 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79998160 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79462334 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76690803 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75943633 |
| 88 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.74020233 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72971556 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70792444 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70678739 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70646879 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69881545 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69835783 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.69163636 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.68697424 |
| 97 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68387827 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67703704 |
| 99 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67703704 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.67356091 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66676132 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66473053 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65252499 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.65069043 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64994011 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.64398784 |
| 107 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.62525905 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.62411140 |
| 109 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.62031253 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.61959599 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61825263 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60596724 |
| 113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.59284971 |
| 114 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.58186854 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.57538388 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57255187 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.55402256 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54600330 |
| 119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.54092336 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.53104236 |
| 121 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52914044 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.52899847 |
| 123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.52899847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.93403259 |
| 2 | MP0009785_altered_susceptibility_to | 4.68993305 |
| 3 | MP0003724_increased_susceptibility_to | 4.15479823 |
| 4 | MP0006082_CNS_inflammation | 4.00825006 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.32391335 |
| 6 | MP0005025_abnormal_response_to | 3.31562462 |
| 7 | MP0005671_abnormal_response_to | 3.26880347 |
| 8 | MP0000685_abnormal_immune_system | 3.21827896 |
| 9 | MP0001790_abnormal_immune_system | 3.15926061 |
| 10 | MP0005387_immune_system_phenotype | 3.15926061 |
| 11 | MP0003436_decreased_susceptibility_to | 3.12241529 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.02530951 |
| 13 | MP0004510_myositis | 2.96769436 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.74516339 |
| 15 | MP0002419_abnormal_innate_immunity | 2.66990219 |
| 16 | MP0002006_tumorigenesis | 2.62759000 |
| 17 | MP0002723_abnormal_immune_serum | 2.59940783 |
| 18 | MP0001800_abnormal_humoral_immune | 2.55989659 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.44472550 |
| 20 | MP0003303_peritoneal_inflammation | 2.34879968 |
| 21 | MP0004947_skin_inflammation | 2.30464571 |
| 22 | MP0001819_abnormal_immune_cell | 2.15713329 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.12197027 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.09874242 |
| 25 | MP0009764_decreased_sensitivity_to | 1.99727546 |
| 26 | MP0008469_abnormal_protein_level | 1.97417344 |
| 27 | MP0005451_abnormal_body_composition | 1.92787109 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.88061406 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.83114895 |
| 30 | MP0000343_altered_response_to | 1.76817471 |
| 31 | MP0003448_altered_tumor_morphology | 1.74512323 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.72156245 |
| 33 | MP0002405_respiratory_system_inflammati | 1.67735916 |
| 34 | MP0001853_heart_inflammation | 1.66915396 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.63318221 |
| 36 | MP0005310_abnormal_salivary_gland | 1.59453083 |
| 37 | MP0000716_abnormal_immune_system | 1.58197186 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.55879790 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.50133417 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.50112554 |
| 41 | MP0002398_abnormal_bone_marrow | 1.48004199 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.44881166 |
| 43 | MP0008004_abnormal_stomach_pH | 1.38117108 |
| 44 | MP0003186_abnormal_redox_activity | 1.37559038 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.37161121 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.34844067 |
| 47 | MP0003075_altered_response_to | 1.33555412 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.32006027 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.31681379 |
| 50 | MP0009840_abnormal_foam_cell | 1.30789594 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.30528132 |
| 52 | MP0002254_reproductive_system_inflammat | 1.28494335 |
| 53 | MP0006054_spinal_hemorrhage | 1.25242971 |
| 54 | MP0000858_altered_metastatic_potential | 1.24473771 |
| 55 | MP0008260_abnormal_autophagy | 1.22463330 |
| 56 | MP0002429_abnormal_blood_cell | 1.21440374 |
| 57 | MP0000604_amyloidosis | 1.19504213 |
| 58 | MP0001958_emphysema | 1.15269045 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.15214517 |
| 60 | MP0009763_increased_sensitivity_to | 1.13583220 |
| 61 | MP0004883_abnormal_blood_vessel | 1.10947997 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.10911012 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.10267942 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.09121920 |
| 65 | MP0002722_abnormal_immune_system | 1.06783939 |
| 66 | MP0009278_abnormal_bone_marrow | 1.05325865 |
| 67 | MP0005166_decreased_susceptibility_to | 1.04728098 |
| 68 | MP0003045_fibrosis | 1.02075150 |
| 69 | MP0005164_abnormal_response_to | 0.98844141 |
| 70 | MP0001851_eye_inflammation | 0.98765584 |
| 71 | MP0005390_skeleton_phenotype | 0.95657512 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.93756527 |
| 73 | MP0002933_joint_inflammation | 0.92726144 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 0.92547558 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.91565893 |
| 76 | MP0001545_abnormal_hematopoietic_system | 0.91565893 |
| 77 | MP0003690_abnormal_glial_cell | 0.90377263 |
| 78 | MP0004858_abnormal_nervous_system | 0.90057205 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.90015847 |
| 80 | MP0003091_abnormal_cell_migration | 0.89273265 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.87627839 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.84670854 |
| 83 | MP0005023_abnormal_wound_healing | 0.83650647 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.81340403 |
| 85 | MP0003866_abnormal_defecation | 0.80675190 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.79738206 |
| 87 | MP0003195_calcinosis | 0.79214231 |
| 88 | MP0000249_abnormal_blood_vessel | 0.77247824 |
| 89 | MP0005083_abnormal_biliary_tract | 0.77066489 |
| 90 | MP0008874_decreased_physiological_sensi | 0.75648685 |
| 91 | MP0001542_abnormal_bone_strength | 0.73879456 |
| 92 | MP0001663_abnormal_digestive_system | 0.73242022 |
| 93 | MP0000920_abnormal_myelination | 0.72744594 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.71324866 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.67717787 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.67091288 |
| 97 | MP0001873_stomach_inflammation | 0.63529166 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63037592 |
| 99 | MP0010307_abnormal_tumor_latency | 0.62779323 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.62090105 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.61825339 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.61480732 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.60641139 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.60549755 |
| 105 | MP0003795_abnormal_bone_structure | 0.60536972 |
| 106 | MP0005275_abnormal_skin_tensile | 0.60441570 |
| 107 | MP0001881_abnormal_mammary_gland | 0.58799678 |
| 108 | MP0002163_abnormal_gland_morphology | 0.55887625 |
| 109 | MP0005165_increased_susceptibility_to | 0.55763126 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.54981860 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.54809517 |
| 112 | MP0003329_amyloid_beta_deposits | 0.54315321 |
| 113 | MP0001915_intracranial_hemorrhage | 0.52845288 |
| 114 | MP0000609_abnormal_liver_physiology | 0.51899095 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.50624715 |
| 116 | MP0003879_abnormal_hair_cell | 0.50281795 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.49966870 |
| 118 | MP0003828_pulmonary_edema | 0.49706425 |
| 119 | MP0003646_muscle_fatigue | 0.49678353 |
| 120 | MP0001191_abnormal_skin_condition | 0.49532576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.42567958 |
| 2 | Increased IgM level (HP:0003496) | 6.31632125 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.84086060 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.56511355 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.38974194 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.15423738 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.88785838 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.65474310 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 4.65474310 |
| 10 | Basal ganglia calcification (HP:0002135) | 4.45274936 |
| 11 | Recurrent skin infections (HP:0001581) | 4.36590762 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.32709033 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.31453575 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.22561784 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.11178879 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.06786527 |
| 17 | Hypergammaglobulinemia (HP:0010702) | 4.00043730 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.97218134 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.83044289 |
| 20 | Chronic otitis media (HP:0000389) | 3.81279172 |
| 21 | Vasculitis (HP:0002633) | 3.72009400 |
| 22 | Recurrent viral infections (HP:0004429) | 3.53990913 |
| 23 | Gingivitis (HP:0000230) | 3.52721434 |
| 24 | Orchitis (HP:0100796) | 3.50935767 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.50277810 |
| 26 | Recurrent bronchitis (HP:0002837) | 3.45220598 |
| 27 | Myositis (HP:0100614) | 3.38376360 |
| 28 | Stomatitis (HP:0010280) | 3.36453565 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.36257983 |
| 30 | Pustule (HP:0200039) | 3.33515187 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 3.14202866 |
| 32 | Encephalitis (HP:0002383) | 3.09748363 |
| 33 | Thick nail (HP:0001805) | 3.08202627 |
| 34 | Optic neuritis (HP:0100653) | 3.05727951 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.05727951 |
| 36 | Tetraparesis (HP:0002273) | 3.04054559 |
| 37 | Periodontitis (HP:0000704) | 2.99889003 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.99031281 |
| 39 | Porencephaly (HP:0002132) | 2.98889899 |
| 40 | Hemoptysis (HP:0002105) | 2.96757424 |
| 41 | Gangrene (HP:0100758) | 2.90582631 |
| 42 | T lymphocytopenia (HP:0005403) | 2.89674931 |
| 43 | Nasal polyposis (HP:0100582) | 2.88791377 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.87669631 |
| 45 | Prostate neoplasm (HP:0100787) | 2.87332000 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82115605 |
| 47 | Leukocytosis (HP:0001974) | 2.82018459 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.79405318 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.75451272 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.75451272 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.74492880 |
| 52 | Cheilitis (HP:0100825) | 2.73842991 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73576776 |
| 54 | Obstructive lung disease (HP:0006536) | 2.73576776 |
| 55 | Increased IgE level (HP:0003212) | 2.68848424 |
| 56 | Joint swelling (HP:0001386) | 2.63754417 |
| 57 | Combined immunodeficiency (HP:0005387) | 2.63355921 |
| 58 | IgG deficiency (HP:0004315) | 2.63351817 |
| 59 | Disinhibition (HP:0000734) | 2.62548285 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.60559252 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.58144106 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.58093279 |
| 63 | Chronic diarrhea (HP:0002028) | 2.57720444 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.57565016 |
| 65 | Abnormality of the endocardium (HP:0004306) | 2.56899977 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.55789809 |
| 67 | Purpura (HP:0000979) | 2.53922365 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.53522525 |
| 69 | Hematochezia (HP:0002573) | 2.52759927 |
| 70 | Urticaria (HP:0001025) | 2.51056596 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48783904 |
| 72 | Pulmonary embolism (HP:0002204) | 2.48559106 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.48123922 |
| 74 | Thyroiditis (HP:0100646) | 2.44744958 |
| 75 | Abnormality of T cells (HP:0002843) | 2.44418266 |
| 76 | Nephritis (HP:0000123) | 2.43979796 |
| 77 | Amyloidosis (HP:0011034) | 2.43492455 |
| 78 | Eosinophilia (HP:0001880) | 2.43398700 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.41265025 |
| 80 | IgA deficiency (HP:0002720) | 2.40368088 |
| 81 | Episodic fever (HP:0001954) | 2.39077895 |
| 82 | Gingival bleeding (HP:0000225) | 2.38599495 |
| 83 | Chronic sinusitis (HP:0011109) | 2.33788488 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32696081 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32696081 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32696081 |
| 87 | Abnormality of the pericardium (HP:0001697) | 2.27075123 |
| 88 | Cellulitis (HP:0100658) | 2.25156341 |
| 89 | Polyneuropathy (HP:0001271) | 2.24005777 |
| 90 | Axonal loss (HP:0003447) | 2.23805965 |
| 91 | Keratitis (HP:0000491) | 2.23361633 |
| 92 | Hypoplasia of the thymus (HP:0000778) | 2.19959009 |
| 93 | Myocardial infarction (HP:0001658) | 2.19847742 |
| 94 | Arterial thrombosis (HP:0004420) | 2.18782925 |
| 95 | Vertigo (HP:0002321) | 2.18767446 |
| 96 | Abnormality of B cell number (HP:0010975) | 2.18604236 |
| 97 | Glomerulopathy (HP:0100820) | 2.18374599 |
| 98 | Acne (HP:0001061) | 2.17290049 |
| 99 | Glomerulonephritis (HP:0000099) | 2.17249955 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17132245 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.17089931 |
| 102 | Petechiae (HP:0000967) | 2.16667296 |
| 103 | Chest pain (HP:0100749) | 2.16032207 |
| 104 | Abnormality of the basal ganglia (HP:0002134) | 2.15653049 |
| 105 | Parakeratosis (HP:0001036) | 2.15514588 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15323578 |
| 107 | Recurrent pneumonia (HP:0006532) | 2.15236449 |
| 108 | Increased serum ferritin (HP:0003281) | 2.14444106 |
| 109 | Premature loss of primary teeth (HP:0006323) | 2.14195000 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.11915316 |
| 111 | Loss of speech (HP:0002371) | 2.11758011 |
| 112 | Esophageal varix (HP:0002040) | 2.11246317 |
| 113 | Mitral stenosis (HP:0001718) | 2.09185721 |
| 114 | Peritonitis (HP:0002586) | 2.08072924 |
| 115 | Arthralgia (HP:0002829) | 2.06865926 |
| 116 | Lymphopenia (HP:0001888) | 2.06349767 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.05023257 |
| 118 | Skin ulcer (HP:0200042) | 2.04882293 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 2.04289020 |
| 120 | Meningitis (HP:0001287) | 2.02961406 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02780065 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02780065 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02780065 |
| 124 | Granulocytopenia (HP:0001913) | 2.01066786 |
| 125 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00091789 |
| 126 | Hypochromic anemia (HP:0001931) | 1.98872483 |
| 127 | Osteomyelitis (HP:0002754) | 1.97713805 |
| 128 | Anorexia (HP:0002039) | 1.96856965 |
| 129 | Poor head control (HP:0002421) | 1.96818962 |
| 130 | Cleft eyelid (HP:0000625) | 1.95194128 |
| 131 | Hypochromic microcytic anemia (HP:0004840) | 1.94914077 |
| 132 | Bone pain (HP:0002653) | 1.94763973 |
| 133 | B lymphocytopenia (HP:0010976) | 1.94050832 |
| 134 | Emphysema (HP:0002097) | 1.93900618 |
| 135 | Bronchitis (HP:0012387) | 1.93852773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IKBKE | 5.18371912 |
| 2 | FGFR4 | 5.10465445 |
| 3 | TYK2 | 4.88594416 |
| 4 | TBK1 | 4.40473398 |
| 5 | MAP3K14 | 3.75029682 |
| 6 | JAK3 | 3.71095419 |
| 7 | KIT | 3.68661936 |
| 8 | JAK1 | 3.23847483 |
| 9 | PBK | 3.10294599 |
| 10 | FGFR3 | 2.87600015 |
| 11 | TXK | 2.83837870 |
| 12 | IRAK4 | 2.29057998 |
| 13 | PRPF4B | 2.24487790 |
| 14 | BLK | 2.22294122 |
| 15 | MAP2K3 | 2.01784656 |
| 16 | TAOK2 | 1.95750348 |
| 17 | RIPK4 | 1.95242960 |
| 18 | ERN1 | 1.94400930 |
| 19 | MAP4K1 | 1.94387031 |
| 20 | IKBKB | 1.83543550 |
| 21 | MAP3K3 | 1.83229788 |
| 22 | TAOK1 | 1.62277569 |
| 23 | CSK | 1.53870073 |
| 24 | MAP3K13 | 1.50260222 |
| 25 | ZAP70 | 1.46996399 |
| 26 | MAP3K11 | 1.46676936 |
| 27 | EPHB1 | 1.40660601 |
| 28 | PIM2 | 1.35595473 |
| 29 | NEK9 | 1.34086273 |
| 30 | EPHA3 | 1.33008988 |
| 31 | MST4 | 1.25022826 |
| 32 | JAK2 | 1.22347802 |
| 33 | CDC42BPA | 1.16328952 |
| 34 | HCK | 1.12543570 |
| 35 | LCK | 1.07615668 |
| 36 | CHUK | 1.05864629 |
| 37 | SYK | 1.04502015 |
| 38 | TNK2 | 0.98000797 |
| 39 | IRAK3 | 0.93080773 |
| 40 | KDR | 0.92194204 |
| 41 | MAPK11 | 0.90078203 |
| 42 | BMPR2 | 0.89078006 |
| 43 | RPS6KA4 | 0.88481002 |
| 44 | BMX | 0.83482817 |
| 45 | IRAK1 | 0.83075879 |
| 46 | LYN | 0.81169965 |
| 47 | TESK1 | 0.80138143 |
| 48 | EIF2AK2 | 0.77621530 |
| 49 | TGFBR2 | 0.74585982 |
| 50 | RIPK1 | 0.73393950 |
| 51 | HIPK2 | 0.73001718 |
| 52 | CSF1R | 0.71891464 |
| 53 | MATK | 0.69566429 |
| 54 | SIK3 | 0.69289723 |
| 55 | TIE1 | 0.68164432 |
| 56 | BTK | 0.66949560 |
| 57 | ARAF | 0.66714219 |
| 58 | PRKCD | 0.63661602 |
| 59 | MARK3 | 0.63514541 |
| 60 | FGR | 0.63087360 |
| 61 | PRKD2 | 0.62540906 |
| 62 | EGFR | 0.61225615 |
| 63 | ABL2 | 0.60633245 |
| 64 | PRKCH | 0.58628978 |
| 65 | MAP3K12 | 0.58232263 |
| 66 | RPS6KA5 | 0.54732609 |
| 67 | MAP2K6 | 0.54363082 |
| 68 | MAP3K5 | 0.54272651 |
| 69 | MST1R | 0.53696427 |
| 70 | MAPK7 | 0.52955265 |
| 71 | KSR2 | 0.52672044 |
| 72 | CLK1 | 0.51515928 |
| 73 | STK10 | 0.50363433 |
| 74 | TRPM7 | 0.48994433 |
| 75 | TTN | 0.48865577 |
| 76 | ABL1 | 0.48751726 |
| 77 | TEC | 0.47974290 |
| 78 | BCR | 0.47735152 |
| 79 | LRRK2 | 0.45503920 |
| 80 | SIK1 | 0.43797646 |
| 81 | PRKCQ | 0.43303289 |
| 82 | FES | 0.43029113 |
| 83 | IRAK2 | 0.42952066 |
| 84 | PIM1 | 0.40791768 |
| 85 | MAP3K6 | 0.40281793 |
| 86 | PDPK1 | 0.37393029 |
| 87 | STK4 | 0.37343188 |
| 88 | TRIB3 | 0.36724181 |
| 89 | NLK | 0.35859599 |
| 90 | YES1 | 0.35550799 |
| 91 | PTK6 | 0.35294923 |
| 92 | MARK2 | 0.34498231 |
| 93 | NME2 | 0.34341648 |
| 94 | ITK | 0.34240382 |
| 95 | DAPK3 | 0.33599201 |
| 96 | TLK1 | 0.33553992 |
| 97 | DYRK3 | 0.33013502 |
| 98 | FYN | 0.32154726 |
| 99 | MOS | 0.31130062 |
| 100 | IGF1R | 0.30712424 |
| 101 | DDR2 | 0.30669823 |
| 102 | ERBB3 | 0.30021426 |
| 103 | TAOK3 | 0.29977925 |
| 104 | SIK2 | 0.29876994 |
| 105 | INSR | 0.28754785 |
| 106 | SRC | 0.26937954 |
| 107 | DAPK2 | 0.26255873 |
| 108 | MAPK4 | 0.24889615 |
| 109 | ACVR1B | 0.23683479 |
| 110 | CAMK2G | 0.23643301 |
| 111 | PDK1 | 0.22277174 |
| 112 | MAP3K1 | 0.21748605 |
| 113 | GRK7 | 0.21277490 |
| 114 | DYRK1B | 0.21043140 |
| 115 | MAPKAPK2 | 0.20385607 |
| 116 | PKN1 | 0.18626775 |
| 117 | MYLK | 0.17712575 |
| 118 | TYRO3 | 0.16892958 |
| 119 | CDK6 | 0.16841804 |
| 120 | PRKG2 | 0.15934747 |
| 121 | TESK2 | 0.15466878 |
| 122 | ADRBK2 | 0.13010710 |
| 123 | PDGFRB | 0.12129729 |
| 124 | PLK2 | 0.10837987 |
| 125 | GRK6 | 0.10742983 |
| 126 | ERBB4 | 0.08766309 |
| 127 | TGFBR1 | 0.07755395 |
| 128 | PTK2 | 0.07078205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.47459884 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.40571559 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.20694515 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.15872640 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.07676976 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02882833 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.97106933 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.93559140 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52663144 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51562940 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.46647705 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.32935579 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32240178 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.27084979 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.20149214 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.16329683 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99460372 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.98928307 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.97700704 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94204597 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.83433582 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.80979702 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80144196 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77804237 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76234607 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74412805 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.72536567 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72003049 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70188644 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61102317 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.56154487 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53306345 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48181339 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45676596 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.42928996 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42017667 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.32906097 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32453193 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30180135 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.22899191 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.22370153 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.21223851 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97314531 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.96963523 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91174141 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89648610 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88181798 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87792909 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80235087 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.77973819 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77153070 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76644168 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76096470 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.75714027 |
| 55 | Proteasome_Homo sapiens_hsa03050 | 0.75147959 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73513823 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73142436 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73043313 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67074684 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60784781 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.54654324 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51536530 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50904528 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48240201 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47064757 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45966528 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40106398 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37873845 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37527170 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35779591 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35035348 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35000081 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34419994 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33478809 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.29947349 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27833180 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26746846 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26261083 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25823106 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25560080 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24794843 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24538295 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.24374280 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23764864 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23171944 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22518445 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22452756 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22332615 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21602671 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18848595 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17875881 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15145984 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14042201 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14023406 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13454422 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13066789 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11628750 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11207750 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10947836 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10374338 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09822166 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.09776346 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.09600406 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.09159842 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09096989 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08455396 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08059874 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07940032 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.07938704 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.07776810 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.05992705 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.05831877 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05753827 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.05477050 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.05065289 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03398505 |

